HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CLT1 targets bladder cancer through integrin α5β1 and CLIC3.

Abstract
High-grade non-muscle-invasive bladder cancer is commonly treated with Bacillus Calmette-Guérin, an immunotherapeutic that depends on fibronectin and tumor cell integrin α5β1 for internalization into bladder cancer cells. We previously showed that the anti-angiogenic peptide CLT1 forms cytotoxic complexes with fibronectin that are cooperatively internalized into proliferating endothelium through ligation of integrins and chloride intracellular channel 1. While CLT1 has no effect on mature, differentiated cells, we show here that CLT1 is highly cytotoxic for a panel of bladder tumor cell lines as well as a variety of cell lines derived from kidney, lung, breast, and prostate cancer. Paralleling our previous results, we found CLT1-induced tumor cell death to be increased in the presence of fibronectin, which mediated CLT1 internalization and subsequent autophagic cell death in a mechanism that depends on tumor cell integrin α5β1 and chloride intracellular channel 3 (CLIC3). This mechanistic link was further supported by our results showing upregulation of α5β1 and CLIC3 in CLT1-responsive tumor cell lines and colocalization with CLT1 in tumor tissues. Incubating tumor tissue from patients with bladder cancer with fluorescein-conjugated CLT1 resulted in a strong and specific fluorescence whereas normal bladder tissue remained negative. On the basis of its affinity for bladder tumor tissue and strong antitumor effects, we propose that CLT1 could be useful for targeting bladder cancer.
AuthorsLynn M Knowles, James Zewe, Gunjan Malik, Anil V Parwani, Jeffrey R Gingrich, Jan Pilch
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 11 Issue 2 Pg. 194-203 (Feb 2013) ISSN: 1557-3125 [Electronic] United States
PMID23204394 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Fibronectins
  • Integrin alpha5beta1
  • Oligopeptides
  • Peptides, Cyclic
  • RNA, Small Interfering
  • cyclo(cysteinyl-glycyl-leucyl-isoleucyl-isoleucyl-glutaminyl-lysyl-asparaginyl-glutamyl-cysteinyl)
Topics
  • Autophagy (drug effects)
  • Cell Line, Tumor
  • Fibronectins (pharmacology)
  • Gene Silencing
  • Humans
  • Integrin alpha5beta1 (genetics, metabolism)
  • Molecular Targeted Therapy
  • Neovascularization, Pathologic (drug therapy, metabolism)
  • Oligopeptides (pharmacology)
  • Peptides, Cyclic (pharmacokinetics, pharmacology)
  • RNA, Small Interfering (administration & dosage, genetics)
  • Signal Transduction
  • Urinary Bladder Neoplasms (blood supply, drug therapy, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: